WallStreetZenWallStreetZen

NASDAQ: GUTS
Fractyl Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for GUTS

Based on 1 analyst offering 12 month price targets for Fractyl Health Inc.
Min Forecast
$18.00+168.66%
Avg Forecast
$18.00+168.66%
Max Forecast
$18.00+168.66%

Should I buy or sell GUTS stock?

Based on 1 analyst offering ratings for Fractyl Health Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GUTS stock forecasts and price targets.

GUTS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-27

1 of 1

Forecast return on equity

Is GUTS forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is GUTS forecast to generate an efficient return on assets?

GUTS revenue forecast

What is GUTS's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$12.4M+10,261.67%
GUTS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GUTS revenue growth forecast

How is GUTS forecast to perform vs Biotechnology companies and vs the US market?
Company
1,336.08%
Industry
61.06%
Market
9.11%
GUTS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GUTS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GUTS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GUTS$6.70$18.00+168.66%Strong Buy
ATAI$1.93$10.50+444.04%Strong Buy
TERN$4.91$13.50+174.95%Buy
IMMP$2.65N/AN/A
AVIR$3.71N/AN/A

Fractyl Health Stock Forecast FAQ

Is Fractyl Health Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GUTS) stock is to Strong Buy GUTS stock.

Out of 1 analyst, 1 (100%) are recommending GUTS as a Strong Buy, 0 (0%) are recommending GUTS as a Buy, 0 (0%) are recommending GUTS as a Hold, 0 (0%) are recommending GUTS as a Sell, and 0 (0%) are recommending GUTS as a Strong Sell.

If you're new to stock investing, here's how to buy Fractyl Health stock.

What is GUTS's revenue growth forecast for 2026-2026?

(NASDAQ: GUTS) Fractyl Health's forecast annual revenue growth rate of 1,336.08% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 61.06%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.11%.

Fractyl Health's revenue in 2024 is $120,000.

In 2026, GUTS is forecast to generate $595,318,397 in revenue, with the lowest revenue forecast at $595,318,397 and the highest revenue forecast at $595,318,397.

What is GUTS's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: GUTS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 8.04%.

What is GUTS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GUTS price target, the average GUTS price target is $18.00, with the highest GUTS stock price forecast at $18.00 and the lowest GUTS stock price forecast at $18.00.

The Wall Street analyst predicted that Fractyl Health's share price could reach $18.00 by Feb 27, 2025. The average Fractyl Health stock price prediction forecasts a potential upside of 168.66% from the current GUTS share price of $6.70.

What is GUTS's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: GUTS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.